MicroSintesis Inc.

$50,000.00 CAD

≈ 8 months of average Canadian pay
Department
National Research Council Canada
Program
Industrial Research Assistance Program – Contributions to Firms
Recipient country
Canada
Fiscal year
2017-2018
Agreement period
March 12, 2018 – August 13, 2018
Reference
nrc-cnrc:172-2018-2019-Q1-903230

Published purpose

MicroSintesis is a new biotechnology company specializing in the science of proteobiotics, bio-active metabolites produced by probiotics. Using proprietary fermentation and strain selection techniques, we are creating a new generation of scientifically advanced probiotics._x000D_ _x000D_ With this project, MicroSintesis will expand the commercial application for our technology and evaluate the efficacy of proteobiotics to impact the ability of the anaerobic pathogen, Clostridium perfringens, to cause infection in poultry. To do this, we will develop the anaerobic assays and production methods to support the pathogen's growth/testing with the goal of creating a new platform of products effective against anaerobic pathogens._x000D_ _x000D_

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions